11 reports

Invasive Meningococcal Disease:

  • Meningococcal
  • World
  • Vaccination Coverage
  • Prescription Drug Sales

meningococcal [serotypes A and C] vaccine

  • Meningococcal
  • World
  • Toyama Prefecture
  • Chongqing Municipality
  • HIV AIDS Prevalence
  • Diagnostic Imaging Density

Meningococcal Vaccine Market by Serogroup (MenACWY, MenB/BC, MenC, MenAC, and MenA), Vaccine Type (Conjugate, Polysaccharide, and Subcapsular), and End User (Pediatric, Adults, and Travelers): Global Opportunity Analysis and Industry Forecast, 2018–2026 The global meningococcal vaccine market was valued at $1,935.5...

  • Vaccine
  • Meningococcal
  • World
  • APAC
  • Health Expenditure

(diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] + pertussis (whole cell) + poliomyelitis + tetanus) (heptavalent) vaccine – Drug Profile

  • Vaccine
  • Meningococcal
  • Infectious Disease
  • Biochemical
  • World
  • China
  • Chongqing Municipality
  • Beijing Municipality
  • Drug Approval

The mission of the MVP is to eliminate meningitis as a public health problem in sub- Saharan Africa through the development, testing, introduction, and widespread use of conjugate meningococcal vaccines.

  • Vaccine
  • Meningococcal
  • Infectious Disease
  • In Vitro Diagnostic Reagent
  • World
  • China
  • India
  • Drug Approval
  • Infectious Disease Incidence

Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Influenza, Hepatitis, Polio, Meningococcal, DTP, Rotavirus, MMR, HPV SUBMARKET: Regional Markets Asia vaccines market is estimated at $7bn in 2018 and is expected to grow at a...

  • Infectious Disease
  • Biotech Vaccine
  • Pharmaceutical
  • Hepatitis
  • Vaccine
  • Influenza
  • Meningococcal
  • Asia

In August 2015, China Food and Drug Administration approved the clinical trial of Group A and Group C Meningococcal Conjugate vaccine developed by Chengdu Olymvax Biopharmaceuticals Inc. Olymvax reported that the subsequent Clinical trial shall be conducted in accordance with the requirements of the provisions in drug clinical trials and in compliance with the Good Clinical Practice.

  • Meningococcal
  • Infectious Disease
  • Vaccine
  • Biopharmaceutical
  • World
  • Chongqing Municipality
  • HIV AIDS Prevalence
  • HIV AIDS Mortality Rate

Invasive meningococcal disease (IMD) is a life- threatening condition caused by the bacterium Neisseria meningitidis (N. meningitidis), an encapsulated gram-negative diplococcus that is a pathogen exclusive to humans.

  • Meningococcal
  • Epidemiology
  • United States
  • Brazil
  • Japan
  • Germany
  • Italy
  • Infectious Disease Mortality
  • Health Provider Density

Figure ##: Bexsero for meningococcal disease – SWOT analysis

  • Vaccine
  • Meningococcal
  • United States
  • Vaccination Coverage
  • Elderly Population

Table ## highlights the main symptoms of meningococcal disease.

  • Vaccine
  • Meningococcal
  • United States
  • World
  • Vaccination Coverage
  • Drug Approval

DISEASE OVERVIEW Meningitis is an infection of the meninges, the membranes surrounding the brain and spinal cord. It can be caused by a number of different viral and bacterial pathogens including Haemophilus influenzae b (Hib) and Streptococcus pneumoniae. However, in the US, Neisseria meningitidis is the most...

  • Meningococcal
  • Vaccine
  • World